The European Cancer Organisation aims to create and develop ever-strengthening relationships between European institutions and the European cancer care community, and together with our Member Societies, Patient Advocacy Committee and networks, facilitate collaboration and consensus on focused topics towards tangible and impactful policy improvement.
The strategic objectives that underpin all our policy activity are:
Read more about our policy approval pathway here.
The European Code of Cancer Practice (The Code), translated in several languages, is a citizen and patient-centred manifesto of the core requirements for good clinical cancer practice, in order to improve outcomes for all of Europe’s cancer patients.
Landmark study on the current state of play in Europe’s battle against cancer produced by the European Cancer Organisation for the European Parliament. Read more here.
The quality of cancer care makes a huge difference to patients and their families. It is multidisciplinarity that ensures that there is real teamwork between the healthcare professionals involved in patient care. We have developed a series of papers that advocate for the highest quality standards.
read moreFebruary 2021
On World Cancer Day, Dr Matti Aapro, President of the European Cancer Organisation (E.C.O.), made the following remarks reflecting on the international challenges and opportunities facing the cancer community and the need to face them with confidence and determination together:
Read moreFebruary 2021
Responding to the publication of Europe’s Beating Cancer Plan, Dr Matti Aapro, President of the European Cancer Organisation, made the following statement applauding these goals:
Read moreJanuary 2021
The Community 365 Roundtable Meeting on Lung Cancer, which took place on 7 December 2020, brought together leading policy-makers, politicians, oncology experts, industry partners and advocates to mark the launch of the European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer, published in the journal Lung Cancer,[1] and to discuss this important area of cancer care.
Read moreNovember 2021
The Survivorship and Quality of Life Network of the European Cancer Organisation has collated its recommendations to help more cancer patients and survivors achieve a life truly free from cancer and its often under-appreciated impacts.
Read moreNovember 2020
With many thousands of excess deaths from cancer across Europe now likely as a result of COVID-19 and associated control measures, and in the wake of devastating disruption across all areas of cancer care, the European cancer community has published a ‘7-Point Plan to Address the Urgency and Build Back Better.’
Read moreNovember 2020
The European Cancer Organisation’s new Action Report It Can Be Done — Beating Inequalities in Cancer Care shines a much needed spotlight on inequity that exists in all parts of cancer care, in all countries in Europe. The report focuses especially on the East-West divide in cancer care, as well as the discrimination that can occur against older cancer patients.
Read moreOctober 2020
The European Cancer Organisation’s major new report, Viral Protection: Achieving the Possible. A Four Step Plan for Eliminating HPV Cancers in Europe, calls for urgent action to eliminate most of the 87,000 cancer cases caused in men and women by HPV (human papillomavirus) each year across over 50 countries in the WHO European Region.
Read moreJuly 2020
The European Cancer Organisation was commissioned by the European Parliament to produce a landmark study on the current state of play in Europe’s battle against cancer.
Read moreThe Report of the Mission Board for Cancer ‘Conquering Cancer: Mission Possible’ is the Mission Board’s proposal to the European Commission for a Mission on Cancer. This Mission outline will be used as a basis for further stakeholder and citizen engagement activities in the remainder of 2020 and define a broad strategy for the Horizon Europe Framework Programme.
Read moreThe European Cancer Organisation welcomes the commitment to producing a new EU Pharmaceutical Strategy, and the accompanying commitment to public consultation on its content.
Read moreWhat are the core elements of quality cancer care when it comes to treating and caring for prostate cancer patients? What might improved EU policy be able to achieve in this respect?
Read moreDeveloped in discussion and agreement with members of the European Cancer Organisation and its Patient Advisory Committee, the following 12 points are intended to provide a checklist to ensure that Europe's Beating Cancer Plan meets the needs identified by the stakeholder community.
Read moreThe Board of the European Cancer Organisation has agreed to launch a Special Network on the impact of COVID-19 on Cancer, on a “task and finish” basis to be co-chaired by Board members Mirjam Crul and Mark Lawler.
Read moreWe promote and believe in collaboration as a matter of principle. This high level co-operation should exist between oncology healthcare professionals of different disciplines, between health care sectors and with a wider group of stakeholders in public health.
As part of our Mission and Vision, we work as active members of the following alliances:
To reduce the burden of cancer, improve outcomes and the quality of care for cancer patients, through multidisciplinarity and multiprofessionalism.
As the not-for-profit federation of member organisations working in cancer at a European level, we convene oncology professionals and patients to agree policy, advocate for positive change and be the united voice of the European cancer community.
read more